CIFoundry
Back to Catalog
Drug Discovery

Insilico Medicine Pharma.AI

Save to shortlist
Insilico Medicine, Inc.2021

Last reviewed Nov 11, 2026 against the sources listed on this page · How we review

At a glance

Insilico Medicine's Pharma.AI platform (PandaOmics for target discovery and Chemistry42 for generative chemistry) uses deep learning and generative models to identify disease targets and design…

FDA:
Not on record
Epic:
Not on record
Named users:
Not on record
Published study:
Yes, linked below

Description

Insilico Medicine's Pharma.AI platform (PandaOmics for target discovery and Chemistry42 for generative chemistry) uses deep learning and generative models to identify disease targets and design novel small molecules. Its AI-discovered lead candidate INS018_055, a TNIK inhibitor for idiopathic pulmonary fibrosis, has advanced into clinical trials, one of the first fully generative-AI-originated drugs to do so.

drug discoverygenerative AItarget discoverymedicinal chemistrygenomicsclinical stage

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is there published research on Insilico Medicine Pharma.AI?
Yes, this listing links a study (prospective / randomized study). Check whether the patients and setting in the study look like yours.Some authors of this study work for or have financial ties to the maker.Read the study

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Prospective / randomized study
Study authors
Include people who work for or have financial ties to the maker

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet (checked Oct 2026). Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Drug Discovery

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website Research Paper

Some authors of this study work for or have financial ties to the maker.

https://insilico.com/contact (offices: New York, USA; Hong Kong; Abu Dhabi)

Developer

Insilico Medicine

Insilico Medicine, Inc.

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.